PDIA4 and cancer: Multiple studies have determined that PDIA4 is overexpressed in various cancer cell lines and clinical samples, and is highly associated with the clinical prognosis of cancer patients, which suggests that PDIA4 could be a vital biomarker and target for cancer treatment [14, 15].